ACCD - Accolade Inc Stock Price, Fair Value and News

7.29USD+0.17 (+2.39%)Market Closed

Market Summary

USD7.29+0.17

Market Closed

2.39%

ACCD Alerts

Big jump in Revenue (Y/Y)

Big jump in Earnings (Y/Y)
Losses in recent quarter

ACCD Stock Price

View Fullscreen

ACCD RSI Chart

ACCD Valuation

Market Cap

571.2M

Price/Earnings (Trailing)

-5.72

Price/Sales (Trailing)

1.38

EV/EBITDA

-7.45

Price/Free Cashflow

-27.07

ACCD Price/Sales (Trailing)

ACCD Profitability

EBT Margin

-23.79%

Return on Equity

-22.4%

Return on Assets

-12.66%

Free Cashflow Yield

-3.69%

ACCD Fundamentals

ACCD Revenue

Revenue (TTM)

414.3M

Rev. Growth (Yr)

26.06%

Rev. Growth (Qtr)

25.62%

ACCD Earnings

Earnings (TTM)

-99.8M

Earnings Growth (Yr)

75.33%

Earnings Growth (Qtr)

64.36%

Breaking Down ACCD Revenue

Last 7 days

0.4%

Last 30 days

-24.1%

Last 90 days

-45.8%

Trailing 12 Months

-33.3%

How does ACCD drawdown profile look like?

ACCD Financial Health

Current Ratio

2.64

ACCD Investor Care

Shares Dilution (1Y)

6.41%

Diluted EPS (TTM)

-1.24

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	414.3M	0	0	0
2023	363.1M	370.8M	380.1M	388.5M
2022	310.0M	336.0M	350.4M	357.9M
2021	170.4M	194.0M	230.5M	275.5M
2020	132.5M	139.6M	146.8M	155.6M
2019	94.8M	104.2M	113.7M	123.1M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Accolade Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 02, 2024	mchugh colin	sold	-3,087	7.281	-424	chief accounting officer
May 02, 2024	eskew richard	sold	-3,363	7.281	-462	evp general counsel
May 01, 2024	eskew richard	acquired	-	-	1,638	evp general counsel
May 01, 2024	mchugh colin	acquired	-	-	1,232	chief accounting officer
Apr 18, 2024	singh rajeev	sold	-3,132	8.823	-355	chief executive officer
Apr 18, 2024	barnes stephen h.	sold	-961	8.823	-109	chief financial officer
Apr 18, 2024	hilton michael w	acquired	-	-	331	-
Apr 18, 2024	cavanaugh robert n	sold	-1,244	8.823	-141	president
Apr 17, 2024	barnes stephen h.	acquired	-	-	414	chief financial officer
Apr 17, 2024	cavanaugh robert n	acquired	-	-	510	president

Which funds bought or sold ACCD recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 08, 2024	Russell Investments Group, Ltd.	added	91.11	361	901	-%
May 08, 2024	ProShare Advisors LLC	added	11.1	-4,117	130,707	-%
May 08, 2024	STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	reduced	-35.65	-53,353	179,089	-%
May 08, 2024	US BANCORP \DE\	reduced	-0.24	-118,576	796,994	-%
May 07, 2024	Swiss National Bank	added	1.7	-182,752	1,441,000	-%
May 07, 2024	ClariVest Asset Management LLC	reduced	-0.89	-139,920	895,065	0.09%
May 07, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	reduced	-82.49	-850,288	153,364	-%
May 07, 2024	NEW YORK STATE COMMON RETIREMENT FUND	reduced	-0.06	-47,000	320,000	-%
May 07, 2024	Arizona State Retirement System	reduced	-0.18	-29,702	200,650	-%
May 07, 2024	Inspire Investing, LLC	new	-	359,810	359,810	0.04%

Are Funds Buying or Selling ACCD?

Are funds buying ACCD calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ACCD

No. of Funds

Unveiling Accolade Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	bellevue group ag	5.0%	4	SC 13G/A
Feb 13, 2024	vanguard group inc	6.99%	5,326,212	SC 13G/A
Feb 09, 2024	brown advisory inc	7.6%	5,892,043	SC 13G/A
Jan 29, 2024	ark investment management llc	8.93%	6,805,208	SC 13G/A
Jan 26, 2024	blackrock inc.	7.4%	5,660,665	SC 13G/A
Jan 16, 2024	jpmorgan chase & co	8.2%	6,411,973	SC 13G/A
Feb 14, 2023	bellevue group ag	5.1%	3,677,277	SC 13G
Feb 10, 2023	ark investment management llc	7.59%	5,458,916	SC 13G/A
Feb 09, 2023	vanguard group inc	6.83%	4,916,397	SC 13G/A
Feb 09, 2023	brown advisory inc	6.9%	4,988,021	SC 13G

Recent SEC filings of Accolade Inc

View All Filings

Date Filed	Form Type	Document
May 03, 2024	4	Insider Trading
May 03, 2024	4	Insider Trading
May 02, 2024	144	Notice of Insider Sale Intent
May 02, 2024	144	Notice of Insider Sale Intent
Apr 26, 2024	10-K	Annual Report
Apr 26, 2024	S-8	Employee Benefits Plan
Apr 25, 2024	8-K	Current Report
Apr 19, 2024	4	Insider Trading
Apr 19, 2024	4	Insider Trading
Apr 19, 2024	4	Insider Trading

Peers (Alternatives to Accolade Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	466.7B	379.5B	10.30%	3.46%	30.38	1.23	12.96%	-25.81%
CI	99.7B	206.0B	-1.82%	33.22%	25.87	0.48	12.55%	-43.95%
HCA	84.3B	66.7B	-2.18%	15.50%	15.4	1.26	9.59%	-4.59%
CVS	69.9B	360.9B	-24.11%	-20.14%	9.54	0.19	9.07%	78.49%
CNC	41.4B	155.5B	6.79%	16.14%	15.15	0.27	6.34%	84.42%
DVA	12.1B	12.3B	2.88%	38.95%	14.83	0.98	5.77%	58.74%
UHS	11.9B	14.7B	3.23%	25.09%	14.57	0.81	7.99%	19.23%
MID-CAP
CHE	8.7B	2.3B	-8.08%	4.15%	30.66	3.79	5.96%	18.29%
ACHC	6.5B	3.0B	-7.64%	1.03%	-579.28	2.19	10.92%	-104.06%
AMN	2.3B	3.8B	0.76%	-34.62%	10.95	0.61	-27.73%	-52.50%
AMEH	2.2B	1.5B	-8.15%	19.83%	35.09	1.51	19.34%	40.15%
SMALL-CAP
ADUS	1.7B	1.1B	7.65%	29.55%	26.48	1.6	11.45%	30.74%
BKD	1.4B	3.0B	4.67%	77.04%	-7.95	0.45	4.98%	4.88%
BEAT	53.2M	-	-5.61%	-9.82%	-3.63	-	-	-12.94%
AMS	19.4M	21.3M	3.03%	6.99%	36.34	0.91	8.00%	-62.25%

Accolade Inc News

Latest updates

Accolade Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	25.6%	124,831,000	99,371,000	96,864,000	93,226,000	99,025,000	90,946,000	87,643,000	85,528,000	93,756,000	83,450,000	73,288,000	59,527,000	59,232,000	38,444,000	36,788,000	35,894,000	44,441,000	29,652,000	29,651,000	28,763,000	-
Operating Expenses	-2.7%	74,534,000	76,572,000	76,755,000	78,652,000	79,164,000	80,916,000	83,721,000	383,950,000	79,975,000	11,748,000	103,398,000	71,606,000	36,371,500	32,190,000	28,619,000	26,280,000	23,689,000	29,554,000	27,152,000	26,631,000	-
S&GA Expenses	-5.7%	24,727,000	26,230,000	24,076,000	25,033,000	23,540,000	25,023,000	24,936,000	25,614,000	23,631,000	24,616,000	24,009,000	14,509,000	9,870,500	8,644,000	7,881,000	7,315,000	6,848,000	7,924,000	7,616,000	7,662,000	-
EBITDA Margin	35.4%	-0.12	-0.19	-0.25	-0.29	-1.14	-1.16	-1.00	-1.13	-0.27	-0.25	-0.53	-0.35	-	-	-	-	-	-	-	-	-
Interest Expenses	-93.5%	50,000	770,000	51,000	769,000	101,000	719,000	51,000	769,000	50,000	778,000	51,000	51,000	50,000	52,000	1,608,000	586,000	601,000	589,000	600,000	601,000	-
Income Taxes	120.2%	729,000	331,000	84,000	91,000	-51,000	77,000	249,000	-3,899,000	3,862,000	3,325,000	-12,845,000	19,000	-81,000	29,000	18,000	38,000	80,000	12,000	14,000	23,000	-
Earnings Before Taxes	67.3%	-6,778,000	-20,733,000	-32,741,000	-38,318,000	-30,484,000	-39,795,000	-46,274,000	-346,721,000	-30,694,000	25,828,000	-75,209,000	-48,688,000	-4,807,000	-16,566,000	-15,353,000	-13,922,000	-2,059,000	-18,285,000	-15,012,000	-15,880,000	-
EBT Margin	24.4%	-0.24	-0.31	-0.37	-0.42	-1.28	-1.30	-1.14	-1.27	-0.42	-0.37	-0.63	-0.44	-	-	-	-	-	-	-	-	-
Net Income	64.4%	-7,507,000	-21,064,000	-32,825,000	-38,409,000	-30,433,000	-39,872,000	-46,523,000	-342,822,000	-34,556,000	22,503,000	-62,364,000	-48,707,000	-4,726,000	-16,595,000	-15,371,000	-13,960,000	-2,139,000	-18,297,000	-15,026,000	-15,903,000	-
Net Income Margin	23.7%	-0.24	-0.32	-0.37	-0.42	-1.27	-1.30	-1.15	-1.24	-0.40	-0.34	-0.57	-0.44	-	-	-	-	-	-	-	-	-
Free Cashflow	50.3%	4,916,000	3,270,000	-9,126,000	-20,164,000	-2,763,000	-5,188,000	-3,892,000	-30,967,000	-2,508,000	-22,146,000	-11,902,000	-28,315,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																		(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q1
Assets	0.3%	788	785	854	876	903	914	932	944	1,286	1,263	1,270	891	476	467	267	120	73.00	66.00
Current Assets	4.7%	285	272	336	348	366	366	375	378	409	408	418	453	454	445	243	97.00	49.00	47.00
Cash Equivalents	-19.3%	186	230	292	303	321	326	331	336	366	366	384	326	434	419	222	78.00	33.00	43.00
Net PPE	-0.4%	19.00	19.00	18.00	17.00	15.00	14.00	12.00	12.00	12.00	12.00	12.00	12.00	9.00	10.00	12.00	13.00	14.00	15.00
Goodwill	0%	278	278	278	278	278	278	278	278	578	580	6.00	366	4.00	4.00	4.00	4.00	4.00	-
Liabilities	-2.3%	343	351	417	422	429	428	425	410	430	475	536	454	85.00	79.00	75.00	154	97.00	82.00
Current Liabilities	-6.8%	108	116	109	113	119	117	113	95.00	112	185	249	167	79.00	73.00	69.00	75.00	70.00	57.00
Shareholder's Equity	2.5%	445	435	438	454	474	486	506	535	856	789	734	437	391	388	192	-	-	-
Retained Earnings	-0.7%	-1,054	-1,046	-1,025	-992	-954	-923	-883	-837	-494	-460	-482	-420	-371	-366	-350	-334	-320	-269
Additional Paid-In Capital	1.2%	1,500	1,481	1,463	1,447	1,428	1,410	1,390	1,372	1,350	1,249	1,216	857	762	755	542	68.00	64.00	39.00
Shares Outstanding	1.4%	78.00	77.00	76.00	75.00	73.00	71.00	70.00	70.00	64.00	63.00	61.00	58.00	-	-	-	-	-	-
Float	-	-	-	926	-	-	-	658,500	-	-	-	2,800	-	-	-	960	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	14.3%	5,951	5,205	-8,038	-19,287	-2,559	-4,692	-2,993	-30,461	-2,284	-21,422	-11,030	-27,614	10,396	-12,273	-15,038	-8,317	-10,264	-3,581	-3,522	-16,880	-
Share Based Compensation	-2.2%	15,293	15,644	15,726	14,278	17,835	17,906	17,514	19,389	27,112	18,377	19,775	7,675	3,266	2,946	2,105	1,259	1,107	1,564	1,895	1,436	-
Cashflow From Investing	-1334.6%	-53,254	-3,712	-3,286	-3,377	-2,413	-1,911	-1,632	-1,272	-532	721	64,910	-328,712	-491	-519	-875	-538	-846	-1,405	-1,161	-109	-
Cashflow From Financing	104.7%	3,004	-63,663	641	4,451	418	1,607	-370	1,508	2,687	2,680	4,615	247,950	5,041	209,619	160,342	53,382	4,611	20,710	2,556	345	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

ACCD Income Statement

2024-02-29

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 28, 2022
Income Statement [Abstract]
Revenue	$ 414,292,000	$ 363,142,000	$ 310,021,000
Cost of revenue, excluding depreciation and amortization	222,232,000	198,905,000	169,019,000
Operating expenses:
Product and technology	99,159,000	101,347,000	83,664,000
Sales and marketing	100,066,000	99,113,000	86,765,000
General and administrative	62,124,000	81,209,000	99,106,000
Depreciation and amortization	45,164,000	46,377,000	42,608,000
Goodwill impairment	0	299,705,000	0
Change in fair value of contingent consideration	0	0	(45,416,000)
Total operating expenses	306,513,000	627,751,000	266,727,000
Loss from operations	(114,453,000)	(463,514,000)	(125,725,000)
Interest income (expense), net	5,952,000	255,000	(2,905,000)
Other income (expense)	9,931,000	(15,000)	(133,000)
Loss before income taxes	(98,570,000)	(463,274,000)	(128,763,000)
Income tax benefit (expense)	(1,235,000)	3,624,000	5,639,000
Net loss	$ (99,805,000)	$ (459,650,000)	$ (123,124,000)
Net loss per share, basic (USD per share)	$ (1.33)	$ (6.45)	$ (1.93)
Net loss per share, diluted (USD per share)	$ (1.33)	$ (6.45)	$ (1.93)
Weighted-average common shares outstanding - basic (in shares)	74,906,938	71,279,831	63,823,270
Weighted-average common shares outstanding - diluted (in shares)	74,906,938	71,279,831	63,823,270
Other comprehensive loss:
Unrealized loss on marketable securities, net	$ (47,000)	$ 0	$ 0
Comprehensive loss	$ (99,852,000)	$ (459,650,000)	$ (123,124,000)

ACCD Balance Sheet

2024-02-29

Consolidated Balance Sheets - USD ($) $ in Thousands	Feb. 29, 2024	Feb. 28, 2023
Current assets:
Cash and cash equivalents	$ 185,718	$ 321,083
Marketable securities	51,315	0
Accounts receivable, net	21,800	23,435
Unbilled revenue	5,902	3,260
Current portion of deferred contract acquisition costs	4,369	4,022
Prepaid and other current assets	15,808	14,149
Total current assets	284,912	365,949
Property and equipment, net	19,140	14,763
Operating lease right-of-use assets	28,340	29,525
Goodwill	278,191	278,191
Intangible assets, net	165,407	203,202
Deferred contract acquisition costs	9,608	9,815
Other assets	2,553	1,624
Total assets	788,151	903,069
Current liabilities:
Accounts payable	13,749	10,155
Accrued expenses and other current liabilities	10,736	11,744
Accrued compensation	23,392	39,346
Due to customers	18,552	15,694
Current portion of deferred revenue	34,770	35,191
Current portion of operating lease liabilities	6,651	7,284
Total current liabilities	107,850	119,414
Loans payable, net of unamortized issuance costs	208,482	282,323
Operating lease liabilities	26,077	27,189
Other noncurrent liabilities	156	203
Deferred revenue	121	154
Total liabilities	342,686	429,283
Commitments and contingencies (Note 14)
Stockholders’ equity
Common stock par value $0.0001; 500,000,000 shares authorized; 78,070,781 and 73,089,075 shares issued and outstanding at February 28(29), 2024 and 2023, respectively	8	7
Additional paid‑in capital	1,499,603	1,428,073
Accumulated other comprehensive loss	(47)	0
Accumulated deficit	(1,054,099)	(954,294)
Total stockholders’ equity	445,465	473,786
Total liabilities and stockholders’ equity	$ 788,151	$ 903,069

About Accolade Inc

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. It also provides medical opinion and decision support services; and technology and administrative services to the medical practice PCs providing virtual primary care services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.

CEO	Mr. Rajeev Singh
WEBSITE	accolade.com
INDUSTRY	Healthcare Plans
EMPLOYEES	2370

Accolade Inc Frequently Asked Questions

What is the ticker symbol for Accolade Inc? What does ACCD stand for in stocks?

ACCD is the stock ticker symbol of Accolade Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Accolade Inc (ACCD)?

As of Thu May 09 2024, market cap of Accolade Inc is 571.22 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ACCD stock?

You can check ACCD's fair value in chart for subscribers.

What is the fair value of ACCD stock?

You can check ACCD's fair value in chart for subscribers. The fair value of Accolade Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Accolade Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ACCD so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Accolade Inc a good stock to buy?

The fair value guage provides a quick view whether ACCD is over valued or under valued. Whether Accolade Inc is cheap or expensive depends on the assumptions which impact Accolade Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ACCD.

What is Accolade Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 09 2024, ACCD's PE ratio (Price to Earnings) is -5.72 and Price to Sales (PS) ratio is 1.38. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ACCD PE ratio will change depending on the future growth rate expectations of investors.